Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

EGM Statement

30 Jun 2008 12:12

RNS Number : 8010X
Vernalis PLC
30 June 2008
 



30 June 2008

VERNALIS PLC

RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 30 JUNE 2008

Vernalis plc announces that all resolutions proposed to shareholders at the Extraordinary General Meeting held earlier today were duly passed.

All resolutions were approved on a show of hands. The number of proxy votes received for each resolution is set out below.

Resolution

For (including discretionary votes)*

Against*

Withheld

Ordinary Resolution

1. To approve the sale by the Company of Apokyn® and the US Commercial Operations

143,094,025

(99.98%)

25,322

(0.02%)

7,576

2. To increase the Company's authorised share capital and to authorise the Directors to allot relevant securities 

143,060,249

(99.98%)

28,285

(0.02%)

38,389

Special Resolution

3. To authorise the Directors to allot equity securities for cash without application of statutory pre-emption rights

142,665,007

(99.72%)

403,407

(0.28%)

58,509

*NB: Percentage of votes cast excludes withheld votes

Vernalis has forwarded to the Document Viewing Facility of the Financial Services Authority two copies of the resolutions passed at the Extraordinary General Meeting. These copies will shortly be available for viewing at the Document Facility, at the address below, from 9.00am to 5.30pm on every weekday except bank holidays.

Document Viewing Facility

The Financial Services Authority

25 The North ColonadeCanary Wharf

London E14 5HS

Tel: 020 7066 1000

Printed copies of the resolutions may be obtained by writing to The Company Secretary, Vernalis plc, Oakdene Court, 613 reading Road, Winnersh, Berkshire RG41 5UA.

Enquiries:

Vernalis plc +44 (0)118 977 3133

Tony Weir, Chief Financial Officer

Brunswick Group +44 (0)20 7404 5959

Jon Coles

Justine McIlroy

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EGMBDLLLVQBLBBQ
Date   Source Headline
16th Mar 20067:02 amRNSPhase IIa Trial of V1003
16th Mar 20067:02 amRNSPreliminary Results
27th Feb 200610:40 amRNSNotice of Results
24th Jan 20067:00 amRNSLaunch of US Sales Force
21st Dec 20052:30 pmRNSDirector/PDMR Shareholding
21st Dec 200511:19 amRNSHolding(s) in Company
20th Dec 20053:38 pmRNSHolding(s) in Company
20th Dec 20057:00 amRNSFrova Safety Study Completed
19th Dec 20057:01 amRNSOncology Collaboration
14th Dec 20058:23 amRNSCompletion - Cita Acquisition
13th Dec 200511:56 amRNSResults of EGM
12th Dec 200511:49 amRNSHolding(s) in Company
24th Nov 20055:00 pmRNSHolding(s) in Company
23rd Nov 20052:27 pmRNSHolding(s) in Company
18th Nov 20057:01 amRNSProposed acquisition of Cita
11th Nov 20054:01 pmRNSHolding(s) in Company
4th Nov 20057:01 amRNSCollaboration with Britannia
4th Nov 20057:01 amRNSVernalis Acquires Apokyn(R)
10th Oct 200512:47 pmRNSHolding(s) in Company
22nd Sep 20057:01 amRNSAppointment of Piper Jaffray
22nd Sep 20057:01 amRNSInterim Results
16th Sep 200512:30 pmRNSHolding(s) in Company
6th Sep 20057:00 amRNSFrovatriptan Phase III
8th Aug 20053:00 pmRNSHolding(s) in Company
27th Jul 20053:35 pmRNSHolding(s) in Company
26th Jul 20057:00 amRNSIonix acquisition completed
6th Jul 20057:00 amRNSAcquisition of Ionix
30th Jun 20055:23 pmRNSHolding(s) in Company
27th Jun 20057:00 amRNSMRM Interim Phase 3 Data
10th Jun 20055:49 pmRNSHolding(s) in Company
7th Jun 20057:00 amRNSVernalis Appoints Head of US
25th May 20053:00 pmRNSResults of the AGM
23rd May 20054:12 pmRNSHolding(s) in Company
26th Apr 20057:00 amRNSAnnual Report and Accounts
22nd Apr 20054:55 pmRNSHolding(s) in Company
13th Apr 20052:30 pmRNSDirector Shareholding
12th Apr 20051:30 pmRNSEndo/Serena launch RALLY
31st Mar 20054:30 pmRNSHolding(s) in Company
31st Mar 20054:30 pmRNSHolding(s) in Company
31st Mar 20057:00 amRNSOncology Research
21st Mar 200510:29 amRNSResult of EGM
24th Feb 20057:04 amRNSPlacing and Open Offer
24th Feb 20057:04 amRNSCo-promotion of Frova
24th Feb 20057:03 amRNSPreliminary Announcement
14th Feb 20054:58 pmRNSHolding(s) in Company
19th Jan 20057:00 amRNSStarts Clinical Trials

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.